Symbol:
Nxn
Name:
nucleoredoxin
RGD ID:
1310489
Description:
Predicted to enable thioredoxin-disulfide reductase (NADPH) activity. Predicted to be involved in several processes, including Wnt signaling pathway; negative regulation of Wnt signaling pathway; and negative regulation of protein ubiquitination. Predicted to act upstream of or within in utero embryonic development. Predicted to be active in nucleus. Human ortholog(s) of this gene implicated in autosomal recessive Robinow syndrome 2. Orthologous to human NXN (nucleoredoxin); INTERACTS WITH 1,3-dinitrobenzene; 2,4-dinitrotoluene; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC360577
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
NXN (nucleoredoxin) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Nxn (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Nxn (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
NXN (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
NXN (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Nxn (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
NXN (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
NXN (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Nxn (nucleoredoxin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
NXN (nucleoredoxin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Nxn (nucleoredoxin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
nxn (nucleoredoxin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
nxn
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 61,607,557 - 61,745,807 (-) NCBI GRCr8 mRatBN7.2 10 61,109,322 - 61,247,578 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 61,110,020 - 61,248,251 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 65,751,867 - 65,893,235 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 65,257,315 - 65,398,693 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 60,727,671 - 60,868,987 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 64,411,710 - 64,550,147 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 64,412,833 - 64,550,145 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 63,464,225 - 63,602,662 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 67,775,938 - 67,913,018 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 67,789,548 - 67,927,072 (+) NCBI Celera 10 60,125,836 - 60,262,704 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Nxn Rat (E,E)-2,4-hexadienal affects response to substance ISO NXN (Homo sapiens) 6480464 NXN gene SNP affects the susceptibility to 2 and 4-hexadienal CTD PMID:25622337 Nxn Rat 1,2-dimethylhydrazine multiple interactions ISO Nxn (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NXN mRNA CTD PMID:22206623 Nxn Rat 1,2-dimethylhydrazine increases expression ISO Nxn (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of NXN mRNA CTD PMID:22206623 Nxn Rat 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of NXN mRNA CTD PMID:21983209 Nxn Rat 17beta-estradiol increases expression ISO Nxn (Mus musculus) 6480464 Estradiol results in increased expression of NXN mRNA CTD PMID:19484750 Nxn Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Nxn (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Nxn Rat 2,4,6-tribromophenol increases expression ISO NXN (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Nxn Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of NXN mRNA CTD PMID:21346803 Nxn Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO NXN (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of NXN protein CTD PMID:31675489 Nxn Rat 3-methylcholanthrene decreases expression ISO Nxn (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of NXN mRNA CTD PMID:29554273 Nxn Rat 4,4'-sulfonyldiphenol increases expression ISO Nxn (Mus musculus) 6480464 bisphenol S results in increased expression of NXN mRNA CTD PMID:30951980 Nxn Rat 4,4'-sulfonyldiphenol multiple interactions ISO NXN (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in decreased methylation of NXN gene CTD PMID:31601247 Nxn Rat 4,4'-sulfonyldiphenol affects methylation ISO NXN (Homo sapiens) 6480464 bisphenol S affects the methylation of NXN gene CTD PMID:31601247 Nxn Rat 4-hydroxyphenyl retinamide increases expression ISO Nxn (Mus musculus) 6480464 Fenretinide results in increased expression of NXN mRNA CTD PMID:28973697 Nxn Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NXN mRNA CTD PMID:22504374 Nxn Rat 8-Br-cAMP increases expression ISO NXN (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NXN mRNA CTD PMID:22079614 Nxn Rat aflatoxin B1 increases methylation ISO NXN (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of NXN intron and Aflatoxin B1 results in increased methylation of NXN promoter CTD PMID:30157460 Nxn Rat Aflatoxin B2 alpha affects methylation ISO NXN (Homo sapiens) 6480464 aflatoxin B2 affects the methylation of NXN intron CTD PMID:30157460 Nxn Rat all-trans-retinoic acid increases expression ISO Nxn (Mus musculus) 6480464 Tretinoin results in increased expression of NXN mRNA CTD PMID:16604517 Nxn Rat antirheumatic drug increases expression ISO NXN (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of NXN mRNA CTD PMID:24449571 Nxn Rat arsane affects methylation ISO NXN (Homo sapiens) 6480464 Arsenic affects the methylation of NXN gene CTD PMID:25304211 Nxn Rat arsenic atom affects methylation ISO NXN (Homo sapiens) 6480464 Arsenic affects the methylation of NXN gene CTD PMID:25304211 Nxn Rat benzo[a]pyrene decreases expression ISO Nxn (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of NXN mRNA CTD PMID:21569818 Nxn Rat benzo[a]pyrene affects methylation ISO NXN (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of NXN intron CTD PMID:30157460 Nxn Rat benzo[a]pyrene decreases expression ISO NXN (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of NXN mRNA CTD PMID:20106945 and PMID:21632981 Nxn Rat benzo[e]pyrene affects methylation ISO NXN (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of NXN intron CTD PMID:30157460 Nxn Rat bis(2-ethylhexyl) phthalate decreases expression ISO Nxn (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of NXN mRNA and Diethylhexyl Phthalate results in decreased expression of NXN protein CTD PMID:36356568 Nxn Rat bisphenol A decreases expression ISO NXN (Homo sapiens) 6480464 bisphenol A results in decreased expression of NXN mRNA and bisphenol A results in decreased expression of NXN protein CTD PMID:22576693 and PMID:31675489 Nxn Rat bisphenol A increases expression ISO Nxn (Mus musculus) 6480464 bisphenol A results in increased expression of NXN mRNA CTD PMID:32156529 Nxn Rat bisphenol A affects methylation ISO NXN (Homo sapiens) 6480464 bisphenol A affects the methylation of NXN gene CTD PMID:31601247 Nxn Rat bisphenol A multiple interactions ISO NXN (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of NXN gene CTD PMID:31601247 Nxn Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NXN mRNA CTD PMID:34947998 and PMID:38750585 Nxn Rat bisphenol A increases methylation ISO NXN (Homo sapiens) 6480464 bisphenol A results in increased methylation of NXN gene CTD PMID:22576693 Nxn Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of NXN mRNA CTD PMID:19167457 Nxn Rat cadmium atom multiple interactions ISO NXN (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NXN mRNA CTD PMID:35301059 Nxn Rat cadmium atom multiple interactions ISO Nxn (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NXN mRNA CTD PMID:37325564 Nxn Rat cadmium dichloride multiple interactions ISO NXN (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NXN mRNA CTD PMID:35301059 Nxn Rat cadmium dichloride multiple interactions ISO Nxn (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NXN mRNA CTD PMID:37325564 Nxn Rat calcium dichloride increases expression ISO NXN (Homo sapiens) 6480464 Calcium Chloride results in increased expression of NXN protein CTD PMID:25824407 Nxn Rat carbon nanotube increases expression ISO Nxn (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Nxn Rat choline multiple interactions ISO Nxn (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NXN gene CTD PMID:20938992 Nxn Rat chrysene increases expression ISO Nxn (Mus musculus) 6480464 chrysene results in increased expression of NXN mRNA CTD PMID:26377693 Nxn Rat cisplatin increases expression ISO Nxn (Mus musculus) 6480464 Cisplatin results in increased expression of NXN mRNA CTD PMID:24865317 Nxn Rat cisplatin multiple interactions ISO Nxn (Mus musculus) 6480464 Lutein inhibits the reaction [Cisplatin results in increased expression of NXN mRNA] CTD PMID:24865317 Nxn Rat clobetasol increases expression ISO Nxn (Mus musculus) 6480464 Clobetasol results in increased expression of NXN mRNA CTD PMID:27462272 Nxn Rat clofibrate multiple interactions ISO Nxn (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NXN mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NXN mRNA] CTD PMID:17585979 Nxn Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of NXN mRNA CTD PMID:26577399 Nxn Rat cyclosporin A decreases expression ISO NXN (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NXN mRNA CTD PMID:27989131 Nxn Rat DDE increases expression ISO NXN (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of NXN mRNA CTD PMID:38568856 Nxn Rat decabromodiphenyl ether increases expression ISO NXN (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of NXN protein CTD PMID:31675489 Nxn Rat dextran sulfate decreases expression ISO Nxn (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of NXN protein CTD PMID:35362542 Nxn Rat dextran sulfate multiple interactions ISO Nxn (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of NXN protein] CTD PMID:35362542 Nxn Rat ethanol affects expression ISO Nxn (Mus musculus) 6480464 Ethanol affects the expression of NXN mRNA CTD PMID:30319688 Nxn Rat Evodiamine multiple interactions ISO Nxn (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of NXN protein] CTD PMID:35362542 Nxn Rat folic acid multiple interactions ISO Nxn (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Nxn Rat folic acid decreases expression ISO Nxn (Mus musculus) 6480464 Folic Acid results in decreased expression of NXN mRNA CTD PMID:25629700 Nxn Rat fonofos increases methylation ISO NXN (Homo sapiens) 6480464 Fonofos results in increased methylation of NXN promoter CTD PMID:22847954 Nxn Rat fulvestrant multiple interactions ISO NXN (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of NXN gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of NXN gene CTD PMID:31601247 Nxn Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of NXN mRNA CTD PMID:21396975 Nxn Rat ivermectin decreases expression ISO NXN (Homo sapiens) 6480464 Ivermectin results in decreased expression of NXN protein CTD PMID:32959892 Nxn Rat L-methionine multiple interactions ISO Nxn (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NXN gene CTD PMID:20938992 Nxn Rat lead(0) affects expression ISO NXN (Homo sapiens) 6480464 Lead affects the expression of NXN mRNA CTD PMID:28903495 Nxn Rat lutein increases expression ISO Nxn (Mus musculus) 6480464 Lutein results in increased expression of NXN mRNA CTD PMID:24865317 Nxn Rat lutein multiple interactions ISO Nxn (Mus musculus) 6480464 Lutein inhibits the reaction [Cisplatin results in increased expression of NXN mRNA] CTD PMID:24865317 Nxn Rat methapyrilene affects methylation ISO NXN (Homo sapiens) 6480464 Methapyrilene affects the methylation of NXN intron CTD PMID:30157460 Nxn Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of NXN mRNA CTD PMID:22504374 Nxn Rat methotrexate decreases expression ISO NXN (Homo sapiens) 6480464 Methotrexate results in decreased expression of NXN mRNA CTD PMID:17400583 Nxn Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of NXN gene CTD PMID:35440735 Nxn Rat N-nitrosodiethylamine increases expression ISO Nxn (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of NXN mRNA CTD PMID:24535843 Nxn Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NXN mRNA CTD PMID:25729387 Nxn Rat paracetamol multiple interactions ISO Nxn (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NXN mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NXN mRNA] CTD PMID:17585979 Nxn Rat paracetamol increases expression ISO NXN (Homo sapiens) 6480464 Acetaminophen results in increased expression of NXN mRNA CTD PMID:29067470 Nxn Rat parathion increases methylation ISO NXN (Homo sapiens) 6480464 Parathion results in increased methylation of NXN promoter CTD PMID:22847954 Nxn Rat rotenone increases expression ISO Nxn (Mus musculus) 6480464 Rotenone results in increased expression of NXN mRNA CTD PMID:32937126 Nxn Rat SB 431542 multiple interactions ISO NXN (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NXN protein CTD PMID:37664457 Nxn Rat silver atom increases expression ISO Nxn (Mus musculus) 6480464 Silver results in increased expression of NXN mRNA CTD PMID:19429238 Nxn Rat silver(0) increases expression ISO Nxn (Mus musculus) 6480464 Silver results in increased expression of NXN mRNA CTD PMID:19429238 Nxn Rat Soman increases expression EXP 6480464 Soman results in increased expression of NXN mRNA CTD PMID:19281266 Nxn Rat temozolomide increases expression ISO NXN (Homo sapiens) 6480464 Temozolomide results in increased expression of NXN mRNA CTD PMID:31758290 Nxn Rat terbufos increases methylation ISO NXN (Homo sapiens) 6480464 terbufos results in increased methylation of NXN promoter CTD PMID:22847954 Nxn Rat tetrachloromethane affects expression ISO Nxn (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of NXN mRNA CTD PMID:17484886 Nxn Rat titanium dioxide increases methylation ISO Nxn (Mus musculus) 6480464 titanium dioxide results in increased methylation of NXN gene CTD PMID:35295148 Nxn Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NXN mRNA CTD PMID:25729387 Nxn Rat trichostatin A affects expression ISO NXN (Homo sapiens) 6480464 trichostatin A affects the expression of NXN mRNA CTD PMID:28542535 Nxn Rat trovafloxacin decreases expression ISO Nxn (Mus musculus) 6480464 trovafloxacin results in decreased expression of NXN mRNA CTD PMID:35537566 Nxn Rat tunicamycin decreases expression ISO NXN (Homo sapiens) 6480464 Tunicamycin results in decreased expression of NXN mRNA CTD PMID:22378314 Nxn Rat valproic acid increases expression ISO NXN (Homo sapiens) 6480464 Valproic Acid results in increased expression of NXN mRNA CTD PMID:19101580 Nxn Rat valproic acid affects expression ISO NXN (Homo sapiens) 6480464 Valproic Acid affects the expression of NXN mRNA CTD PMID:25979313 Nxn Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NXN mRNA CTD PMID:22570695
(E,E)-2,4-hexadienal (ISO) 1,2-dimethylhydrazine (ISO) 1,3-dinitrobenzene (EXP) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,4,6-tribromophenol (ISO) 2,4-dinitrotoluene (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-methylcholanthrene (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) 8-Br-cAMP (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (ISO) benzo[e]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (ISO) calcium dichloride (ISO) carbon nanotube (ISO) choline (ISO) chrysene (ISO) cisplatin (ISO) clobetasol (ISO) clofibrate (ISO) Cuprizon (EXP) cyclosporin A (ISO) DDE (ISO) decabromodiphenyl ether (ISO) dextran sulfate (ISO) ethanol (ISO) Evodiamine (ISO) folic acid (ISO) fonofos (ISO) fulvestrant (ISO) indole-3-methanol (EXP) ivermectin (ISO) L-methionine (ISO) lead(0) (ISO) lutein (ISO) methapyrilene (ISO) methimazole (EXP) methotrexate (ISO) methoxychlor (EXP) N-nitrosodiethylamine (ISO) oxaliplatin (EXP) paracetamol (ISO) parathion (ISO) rotenone (ISO) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) Soman (EXP) temozolomide (ISO) terbufos (ISO) tetrachloromethane (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) trovafloxacin (ISO) tunicamycin (ISO) valproic acid (ISO) vinclozolin (EXP)
Nxn Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 61,607,557 - 61,745,807 (-) NCBI GRCr8 mRatBN7.2 10 61,109,322 - 61,247,578 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 61,110,020 - 61,248,251 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 65,751,867 - 65,893,235 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 65,257,315 - 65,398,693 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 60,727,671 - 60,868,987 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 64,411,710 - 64,550,147 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 64,412,833 - 64,550,145 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 63,464,225 - 63,602,662 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 67,775,938 - 67,913,018 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 67,789,548 - 67,927,072 (+) NCBI Celera 10 60,125,836 - 60,262,704 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
NXN Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 799,310 - 979,776 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 799,310 - 979,776 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 702,550 - 883,016 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 649,335 - 829,760 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 649,334 - 829,760 NCBI Celera 17 714,726 - 894,595 (-) NCBI Celera Cytogenetic Map 17 p13.3 NCBI HuRef 17 612,981 - 789,470 (-) NCBI HuRef CHM1_1 17 711,357 - 891,770 (-) NCBI CHM1_1 T2T-CHM13v2.0 17 685,572 - 866,169 (-) NCBI T2T-CHM13v2.0
Nxn Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 76,148,052 - 76,289,967 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 76,148,024 - 76,289,966 (-) Ensembl GRCm39 Ensembl GRCm38 11 76,257,226 - 76,399,141 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 76,257,198 - 76,399,140 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 76,070,728 - 76,212,643 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 76,074,153 - 76,215,336 (-) NCBI MGSCv36 mm8 Celera 11 83,770,072 - 83,910,908 (-) NCBI Celera Cytogenetic Map 11 B5 NCBI cM Map 11 45.92 NCBI
Nxn Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955481 2,338,445 - 2,481,557 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955481 2,338,005 - 2,481,557 (-) NCBI ChiLan1.0 ChiLan1.0
NXN Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 8,348,844 - 8,533,378 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 10,320,098 - 10,504,511 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 769,179 - 946,981 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 690,089 - 720,659 (-) NCBI panpan1.1 PanPan1.1 panPan2
NXN Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 44,847,468 - 45,003,129 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 44,847,558 - 44,998,906 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 43,998,054 - 44,150,808 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 45,664,165 - 45,818,376 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 45,664,254 - 45,816,996 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 44,443,986 - 44,597,122 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 44,729,843 - 44,890,725 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 44,816,642 - 44,969,467 (+) NCBI UU_Cfam_GSD_1.0
Nxn
NXN Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 46,904,407 - 47,075,432 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 46,909,175 - 47,075,435 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 49,205,888 - 49,239,692 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NXN
Nxn
.
Predicted Target Of
Count of predictions: 136 Count of miRNA genes: 103 Interacting mature miRNAs: 108 Transcripts: ENSRNOT00000050232 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
61441 Btemp1 Thermal response to stress QTL 1 4 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 10 35392457 63642539 Rat 1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 152025227 Bw195 Body weight QTL 195 5.73 body mass (VT:0001259) 10 46989699 68663659 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 152025224 Bw193 Body weight QTL 193 6.47 body mass (VT:0001259) 10 51663405 75085664 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 2298544 Neuinf9 Neuroinflammation QTL 9 4.6 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 10 5801990 62146030 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 1598852 Anxrr19 Anxiety related response QTL 19 5.07 body movement coordination trait (VT:0005424) number of rearing movements in an experimental apparatus (CMO:0001752) 10 18167841 63167841 Rat 1581497 Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 21329805 61345413 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 1358897 Stresp6 Stress response QTL 6 4.17 0.022 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 35392267 64155584 Rat 1331762 Rf40 Renal function QTL 40 3.873 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 10 29299504 64155584 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2306787 Ean3 Experimental allergic neuritis QTL 3 3.1 nervous system integrity trait (VT:0010566) body weight loss (CMO:0001399) 10 53797385 66979128 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 10 26521957 61345413 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 2313087 Bmd80 Bone mineral density QTL 80 3.2 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 10 19606483 64606483 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2313055 Bw96 Body weight QTL 96 3.6 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 10 19606483 64606483 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
D10Rat243
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 61,746,532 - 61,746,756 (+) Marker Load Pipeline mRatBN7.2 10 61,248,303 - 61,248,527 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,550,912 - 64,551,135 NCBI Rnor6.0 Rnor_5.0 10 63,463,237 - 63,463,460 UniSTS Rnor5.0 RGSC_v3.4 10 67,774,947 - 67,775,171 RGD RGSC3.4 RGSC_v3.4 10 67,774,948 - 67,775,171 UniSTS RGSC3.4 RGSC_v3.1 10 67,788,570 - 67,788,794 RGD Celera 10 60,263,471 - 60,263,702 UniSTS SHRSP x BN Map 10 45.3799 UniSTS SHRSP x BN Map 10 45.3799 RGD Cytogenetic Map 10 q26 UniSTS
D11Bhm34
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 61,112,906 - 61,113,030 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,415,294 - 64,415,417 NCBI Rnor6.0 Rnor_5.0 10 63,598,955 - 63,599,078 UniSTS Rnor5.0 RGSC_v3.4 10 67,910,434 - 67,910,557 UniSTS RGSC3.4 Celera 10 60,128,297 - 60,128,420 UniSTS Cytogenetic Map 10 q26 UniSTS
BE118869
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 61,156,882 - 61,157,034 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,459,266 - 64,459,417 NCBI Rnor6.0 Rnor_5.0 10 63,554,955 - 63,555,106 UniSTS Rnor5.0 RGSC_v3.4 10 67,866,434 - 67,866,585 UniSTS RGSC3.4 Celera 10 60,172,171 - 60,172,322 UniSTS Cytogenetic Map 10 q26 UniSTS
D11Bhm36
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 61,146,484 - 61,146,645 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,448,869 - 64,449,029 NCBI Rnor6.0 Rnor_5.0 10 63,565,343 - 63,565,503 UniSTS Rnor5.0 RGSC_v3.4 10 67,876,822 - 67,876,982 UniSTS RGSC3.4 Celera 10 60,161,774 - 60,161,934 UniSTS Cytogenetic Map 10 q26 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000050232 ⟹ ENSRNOP00000047264
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,110,429 - 61,247,522 (-) Ensembl Rnor_6.0 Ensembl 10 64,412,833 - 64,550,145 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000114535 ⟹ ENSRNOP00000085662
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,110,020 - 61,248,251 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000118517 ⟹ ENSRNOP00000082978
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,110,020 - 61,118,011 (-) Ensembl
RefSeq Acc Id:
NM_001399571 ⟹ NP_001386500
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,607,557 - 61,745,807 (-) NCBI mRatBN7.2 10 61,109,322 - 61,247,578 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000047264 ⟸ ENSRNOT00000050232
Ensembl Acc Id:
ENSRNOP00000085662 ⟸ ENSRNOT00000114535
Ensembl Acc Id:
ENSRNOP00000082978 ⟸ ENSRNOT00000118517
RefSeq Acc Id:
NP_001386500 ⟸ NM_001399571
- UniProtKB:
A0A8I6A4C2 (UniProtKB/TrEMBL), A6HGV4 (UniProtKB/TrEMBL)
RGD ID: 13697455 Promoter ID: EPDNEW_R7979 Type: initiation region Name: Nxn_1 Description: nucleoredoxin SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 64,550,186 - 64,550,246 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Nxn
nucleoredoxin
Nxn_predicted
nucleoredoxin (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Nxn_predicted
nucleoredoxin (predicted)
Symbol and Name status set to approved
70820 APPROVED
